{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:20:21Z","timestamp":1789132821782,"version":"build-2803163510"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Cytopenias in systemic lupus erythematosus (SLE) require clinical and laboratory workup and bone marrow (BM) examination to determine the cause and for appropriate patient management. Common causes include an increase in SLE activity, immune-mediated hemolysis, iron deficiency, antiphospholipid antibody syndrome, infection, or the effect of medications. We retrospectively evaluated the clinical and laboratory findings of patients with SLE and cytopenias who had undergone BM studies to determine the indicators of malignancy.<\/jats:p>\n            <jats:p>We retrospectively reviewed medical records of patients with SLE who presented with cytopenias for their disease course, medications, laboratory parameters and documented the spectrum of morphological changes in BM including CD34 expression.<\/jats:p>\n            <jats:p>Twenty patients with SLE had undergone BM biopsy for evaluation of cytopenias. 14\/20 (70%) of the patients had reactive BM, and the rest had hematologic malignancies involving the BM. Of these 14 patients, 8 had hypocellular marrow with loss of precursor cells (low CD34), 4 had left shift in myeloid lineage, 3 had serous atrophy, and 1had multilineage dysplasia. The 6 patients with hematologic malignancies included 2 with diffuse large B cell lymphoma, and one each of natural killer\/T cell lymphoma, post-transplant lymphoproliferative disorder, Hodgkin lymphoma, and myelodysplastic syndrome evolving to acute myelogenous leukemia. The presence of autoantibodies, SLE activity, and lupus nephritis were comparable in patients with and without neoplasia. However, the duration of the use of multiple immunosuppressants, years since renal transplant (22 vs 10), multiple transplants, and the presence of other autoimmune diseases were greater in those with neoplasia. Two of the 14 patients with non-neoplastic BM and 1 with the neoplastic BM had nonhematological malignancy.<\/jats:p>\n            <jats:p>Clinical and laboratory findings, the number of transplants, and the use of immunosuppressive agents can guide physicians to identify patients with a higher risk of developing hematologic malignancy. BM findings of cytopenia in SLE are often due to increased disease activity causing global cell death and dysmaturation. SLE patients presenting with cytopenias, with a history of long-term exposure to immunosuppressive drugs, should be regularly screened for hematologic and nonhematologic malignancies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025985","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T15:52:34Z","timestamp":1621957954000},"page":"e25985","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies"],"prefix":"10.1097","volume":"100","author":[{"given":"Sonali","family":"Lanjewar","sequence":"first","affiliation":[{"name":"Department of Pathology, Methodist University Hospital \u2013 University of Tennessee Health Science Center, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel M.","family":"McFarlane","sequence":"additional","affiliation":[{"name":"Department of Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwabna Neil","family":"Parker","sequence":"additional","affiliation":[{"name":"Princess Margaret Hospital, University of West Indies, Nassau, Bahamas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Pathology, State University of New York, Downstate Health Sciences University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Haddadin","sequence":"additional","affiliation":[{"name":"Department of Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Department of Pathology, State University of New York, Downstate Health Sciences University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad","family":"Benyaminov","sequence":"additional","affiliation":[{"name":"Department of Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"Kecelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deana","family":"Lazaro","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brooklyn Veterans Administration Medical Center, Brooklyn, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaheer","family":"Bukhari","sequence":"additional","affiliation":[{"name":"Department of Pathology, State University of New York, Downstate Health Sciences University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raavi","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pathology, State University of New York, Downstate Health Sciences University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5854-0235","authenticated-orcid":false,"given":"M.A.","family":"Haseeb","sequence":"additional","affiliation":[{"name":"Department of Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, NY"},{"name":"Department of Pathology, State University of New York, Downstate Health Sciences University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e000078","DOI":"10.1136\/lupus-2014-000078","article-title":"Haematological manifestations of lupus","volume":"2","author":"Fayyaz","year":"2015","journal-title":"Lupus Sci Med"},{"key":"R4-20250504","first-page":"236","article-title":"Haematological abnormalities in systemic lupus erythematosus","volume":"39","author":"Aleem","year":"2014","journal-title":"Acta Reumatol Port"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/art.1780210503","article-title":"Autoimmune neutropenia in systemic lupus erythematosus","volume":"21","author":"Starkebaum","year":"1978","journal-title":"Arthritis Rheum"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.1780260410","article-title":"Granulopoiesis in systemic lupus erythematosus","volume":"26","author":"Yamasaki","year":"1983","journal-title":"Arthritis Rheum"},{"key":"R7-20250504","first-page":"269","article-title":"Deficiency of T cells in blood and tissues and severity of infections in systemic lupus erythematosus","volume":"67","author":"Bhuyan","year":"1978","journal-title":"Indian J Med Res"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00415-002-0781-6","article-title":"Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations","volume":"249","author":"Silva","year":"2002","journal-title":"J Neurol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0268-960X(93)90006-P","article-title":"Haematological manifestations of systemic lupus erythematosus","volume":"7","author":"Keeling","year":"1993","journal-title":"Blood Rev"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0002-9343(99)80249-6","article-title":"Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations","volume":"99","author":"Abu-Shakra","year":"1995","journal-title":"Am J Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e2818","DOI":"10.1097\/MD.0000000000002818","article-title":"Thrombocytopenia in systemic lupus erythematosus","volume":"95","author":"Jung","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in systemic lupus erythematosus","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders\u2013what are the driving forces?","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1874312901307010087","article-title":"Hematological disorders in patients with systemic lupus erythematosus","volume":"7","author":"Bashal","year":"2013","journal-title":"Open Rheumatol J"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/rheumatology\/kep204","article-title":"Myeloid leukaemia in systemic lupus erythematosus a nested case control study based on Swedish registers","volume":"48","author":"L\u00f6fstr\u00f6m","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1182\/blood.V6.11.1059.1059","article-title":"The hematologic aspects of disseminated (systemic) lupus erythematosus","volume":"6","author":"Michael","year":"1951","journal-title":"Blood"},{"key":"R17-20250504","first-page":"29","article-title":"The bone marrow in systemic lupus erythematosus","volume":"2","author":"Burkhardt","year":"1965","journal-title":"Semin Hematol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jcp.36.11.1219","article-title":"Myelofibrosis as a cause of pancytopenia in systemic lupus erythematosus","volume":"36","author":"Daly","year":"1983","journal-title":"J Clin Pathol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01451051","article-title":"Bone marrow findings in systemic lupus erythematosus patients with peripheral cytopenias","volume":"17","author":"Pereira","year":"1998","journal-title":"Clin Rheumatol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ajh.20593","article-title":"Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study","volume":"81","author":"Voulgarelis","year":"2006","journal-title":"Am J Hematol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"948","DOI":"10.5858\/arpa.2011-0603-OA","article-title":"Bone marrow examination for unexplained cytopenias reveals nonspecific findings in patients with collagen vascular disease","volume":"137","author":"Hunt","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/2193-1801-3-349","article-title":"Bone marrow fibrosis as a feature of systemic lupus erythematosus: a case report and literature review","volume":"3","author":"Chalayer","year":"2014","journal-title":"Springerplus"},{"key":"R23-20250504","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-222096","article-title":"Systemic lupus erythematosus presenting to haematology with pancytopenia and features of macrophage activation syndrome","volume":"2018","author":"Mistry","year":"2018","journal-title":"BMJ Case Rep"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"05","DOI":"10.3109\/00313029109061430","article-title":"Bone marrow findings in lupus patients with pancytopenia","volume":"23","author":"Feng","year":"1991","journal-title":"Pathology"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/0961203309106344","article-title":"Gelatinous transformation of the bone marrow in systemic lupus erythematosus","volume":"18","author":"Yamamoto","year":"2009","journal-title":"Lupus"},{"key":"R26-20250504","first-page":"825","article-title":"Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia","volume":"30","author":"Wanitpongpun","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ajcp\/92.5.650","article-title":"Bone marrow findings in connective tissue disease","volume":"92","author":"Rosenthal","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/0961203314531634","article-title":"Bone marrow analysis of immune cells and apoptosis in patients with systemic lupus erythematosus","volume":"23","author":"Park","year":"2014","journal-title":"Lupus"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.2001.03076.x","article-title":"Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus","volume":"115","author":"Papadaki","year":"2001","journal-title":"Br J Haematol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2169\/internalmedicine.47.0607","article-title":"Reversible bone marrow dysplasia in patients with systemic lupus erythematosus","volume":"47","author":"Oka","year":"2008","journal-title":"Intern Med"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e0122964","DOI":"10.1371\/journal.pone.0122964","article-title":"Systemic lupus erythematous and malignancy risk: a meta-analysis","volume":"10","author":"Cao","year":"2015","journal-title":"PLoS One"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-centre cohort study","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J Autoimmun"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.bjc.6604796","article-title":"Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin lymphoma: a population-based case-control study","volume":"100","author":"Jensen","year":"2009","journal-title":"Br J Cancer"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.semcancer.2013.09.003","article-title":"Antigens in lymphoma development-current knowledge and future directions","volume":"23","author":"Rosenquist","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.2006.069039","article-title":"The relationship between cancer and medication exposures in systemic lupus erythematosus: a case-cohort study","volume":"67","author":"Bernatsky","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.bjc.6605314","article-title":"Glucocorticoid therapy and risk of bladder cancer","volume":"101","author":"Dietrich","year":"2009","journal-title":"Br J Cancer"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1054\/bjoc.2001.1931","article-title":"Nonmelanoma skin cancers and glucocorticoid therapy","volume":"85","author":"Karagas","year":"2001","journal-title":"Br J Cancer"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archinternmed.2007.107","article-title":"Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis","volume":"168","author":"Bernatsky","year":"2008","journal-title":"Arch Intern Med"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br J Cancer"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archinte.1979.03630410067021","article-title":"Acute leukemia and immunosupressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases","volume":"139","author":"Gr\u00fcnwald","year":"1979","journal-title":"Arch Intern Med"},{"key":"R43-20250504","first-page":"1705","article-title":"Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases","volume":"26","author":"Asten","year":"1999","journal-title":"J Rheumatol"},{"key":"R44-20250504","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:17:57Z","timestamp":1746339477000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":44,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025985","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"assertion":[{"value":"2021-02-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}